Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:35 PM
Ignite Modification Date:
2025-12-24 @ 7:35 PM
NCT ID:
NCT05551403
Eligibility Criteria:
Inclusion Criteria:
* In agreement with their own neurologist to initiate adjuvant treatment with cenobamate
* Diagnosed with refractory focal epilepsy, which means two ASMs failed to cause seizure freedom.
* Age of 18 years or older
* Having kept a seizure diary for the past 12 weeks
* At least one seizure in the past 12 weeks.
Exclusion Criteria:
* Photosensitive epilepsy
* Any device or structure in the skull or in close proximity of the head area containing metal, including cochlear implants, implanted neurostimulators, cardiac pacemakers and intracardiac lines.
* Persistent skull opening following trauma or surgery
* Evidence (clinical or radiological) of major structural abnormality of the motor cortex or pyramidal tracts
* Any major psychiatric condition such as a psychotic disorder
* Pregnancy
* Learning disabilities preventing the comprehension of oral and/or written instructions
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05551403
Study Brief:
Protocol Section:
NCT05551403